common.study.topics.clinical

Imaging of LAA Thrombosis

common.study.values.description

“Imaging of LAA Thrombosis”

The purpose of the study is to evaluate a new radiotracer called 64Cu-FBP8 for PET-MR imaging of thrombosis. The tracer has the potential of detecting thrombosis in the left atrial appendage of patients with atrial fibrillation, thereby may provide a non-invasive alternative to the current standard-of-care, transesophageal echocardiography.

common.study.values.location

participant.ui.study.affiliations-map.online-study.header-virtual

participant.ui.study.affiliations-map.online-study.text

participant.ui.study.affiliations-map.legend.locations participant.ui.study.affiliations-map.legend.selected

common.study.values.methods

Pharmaceutical medication involved common.study.methods.has-drugs-yes
Patients and healthy individuals accepted common.study.methods.is-healthy-no

Drug - [64Cu]FBP8

Injection of Copper-64 radiopeptide to detect thrombosis

Device - PET/MR

Whole body imaging using Siemens mMR PET/MR scanner

Procedure - Blood Collection

A total of 9 cc of blood sampled before, during, and after imaging for clinical chemistry

Procedure - Electrocardiogram

A standard 12-lead ECG will be obtained pre-and-post injection with radiotracer

participant.views.study.view.additional

participant.views.study.view.scientific-title

PET-MR Imaging of LAA Thrombosis

common.study.values.clinical-trial-id

NCT03830320

participant.views.study.view.id

epYLra